We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The clinical trial will evaluate the company’s first-of-its-kind dual therapy stent, which was developed to repair vessel injury and regenerate endothelium. Read More
The project is expected to benefit more than 4,000 companies by relieving them of the job of monitoring the medical literature for these substances. Read More